Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1006279PMC
http://dx.doi.org/10.1136/ard.33.4.399-aDOI Listing

Publication Analysis

Top Keywords

proceedings penicillamine
4
penicillamine gold
4
gold rheumatoid
4
rheumatoid arthritis?
4
arthritis? multicentre
4
multicentre trial
4
trial 'blind'
4
'blind' observers
4
observers months
4
proceedings
1

Similar Publications

Article Synopsis
  • Treatment of Na[AuCo(d-pen)] with M(OAc) in water results in ionic crystals with a highly porous 3D framework, featuring approximately 80% porosity due to hydrogen-bonding between anions and cations.
  • Soaking these crystals leads to the formation of a 1D porous framework with about 60% porosity, where anions and cations are linked via coordination and hydrogen bonds.
  • Continued soaking transforms the structure into a denser framework (around 30% porosity), with the process yielding a very dense final product with only about 5% porosity, which shows significant adsorption capacities for various gases.
View Article and Find Full Text PDF

D-Penicillamine for preventing retinopathy of prematurity in preterm infants.

Cochrane Database Syst Rev

September 2013

Pediatrics, Royal Alexandra Hospital, University of Alberta, Edmonton, Alberta, Canada, T5H 3V9.

Background: The rate of retinopathy of prematurity (ROP) in moderately premature infants has decreased dramatically with improved care in the neonatal intensive care unit. A low rate of this disorder was unexpectedly observed among infants treated with intravenous D-penicillamine to prevent hyperbilirubinaemia. This observation led to the investigation of its use, both enterally as well as intravenously, to prevent ROP.

View Article and Find Full Text PDF

Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis.

Cochrane Database Syst Rev

September 2012

School of Community-based Medicine, University of Manchester, Manchester, UK.

Background: Arthritis remains a relatively infrequent complication of cystic fibrosis, but is a cause of significant morbidity when it does occur. Two distinct types of arthritis are described in cystic fibrosis: cystic fibrosis-related arthropathy and hypertrophic osteoarthropathy. Management of arthritis in people with cystic fibrosis is uncertain and complex because of the underlying disease and its treatment.

View Article and Find Full Text PDF

Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis.

Cochrane Database Syst Rev

January 2009

Greater Manchester, Lancashire & South Cumbria Medicines for Children Research Network, 2nd Floor, Colwyn House, Royal Manchester Children's Hospital, Manchester, UK, M27 4HA.

Background: Arthritis remains a relatively infrequent complication of cystic fibrosis, but is a cause of significant morbidity when it does occur. Two distinct types of arthritis are described in cystic fibrosis: cystic fibrosis-related arthropathy and hypertrophic osteoarthropathy. Management of arthritis in people with cystic fibrosis is uncertain and complex because of the underlying disease and its treatment.

View Article and Find Full Text PDF

Fear learning depends on prediction error, or the discrepancy between the actual and expected outcome of a conditioning trial. These experiments used blocking and unblocking designs to study the role of opioid receptors in the nucleus accumbens (Acb) in predictive fear learning. Previous fear conditioning to a context blocked later fear conditioning to a conditioned stimulus (CS) in that context.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!